Market Outlook

By 2035, the U.S. Robot-Assisted Minimally Invasive Surgery Market is projected to reach approximately USD 35.97 billion, expanding at a CAGR of 15.20% during 2026–2035. The market is estimated at USD 8.74 billion in 2025, compared with approximately USD 4.12 billion in 2021, USD 4.89 billion in 2022, USD 5.82 billion in 2023, and USD 7.16 billion in 2024. Values in this report are expressed in USD billions.

Under the current adoption trajectory, the market is expected to rise to approximately USD 10.07 billion in 2026 and USD 17.73 billion by 2030, before approaching USD 36 billion by the end of the forecast period. Growth is being driven by higher robotic procedure penetration, next-generation platform replacement, increasing recurring instrument consumption, migration of selected minimally invasive procedures into outpatient settings, and the arrival of new competitors in soft-tissue, orthopedic, spine, and compact surgical robotics.

The U.S. represents the world’s most developed commercial environment for robot-assisted minimally invasive surgery. Robotic surgery has evolved from a premium technology concentrated in prostatectomy and complex academic centers into a broader surgical infrastructure investment covering general surgery, bariatric surgery, colorectal surgery, gynecology, urology, thoracic surgery, selected cardiac procedures, orthopedics, spine surgery, and increasingly ambulatory procedures. The economic model is also changing. Hospitals are no longer evaluating surgical robots simply as large capital purchases; they are assessing robotic programs based on procedure utilization, surgeon recruitment, instrument pull-through, operating-room standardization, case migration, length of stay, clinical outcomes, and the ability to retain profitable surgical volumes within their networks.

Procedure growth remains a powerful indicator of underlying demand. More than 3.15 million da Vinci procedures were performed globally in 2025, increasing approximately 18% from 2024, while U.S. da Vinci procedure volume grew approximately 15%. General surgery was an especially important contributor, with U.S. general surgery procedures increasing approximately 18%. These figures demonstrate that the next phase of robotic penetration is increasingly being driven by higher-volume general surgical procedures rather than only traditional robotic specialties.

The U.S. installed base is correspondingly substantial. More than 6,000 da Vinci surgical systems were installed in the United States by mid-2025, giving hospitals an established infrastructure of trained surgeons, robotic operating rooms, instrument reprocessing workflows, and dedicated robotic program management. This installed base creates a strong replacement opportunity for newer systems while also creating room for competitive platforms that can address capacity constraints, specialty-specific workflows, outpatient settings, or lower-volume hospitals.

The market outlook is therefore defined by two parallel forces. Large health systems will continue expanding multi-system enterprise robotic programs, while compact, modular, miniaturized, and workflow-assistive robots are opening previously underpenetrated facilities and procedures. As these forces converge, robotic surgery is moving toward a multi-platform environment in which hospitals may operate different systems for different specialties rather than relying on a single robotic architecture.

 

Introduction

According to the U.S. Robot-Assisted Minimally Invasive Surgery Market Report, robot-assisted surgery has become an increasingly important component of U.S. surgical strategy because it combines minimally invasive access with enhanced visualization, instrument articulation, motion scaling, tremor filtration, computer-assisted planning, and increasingly advanced data capabilities.

The addressable market includes capital robotic systems, procedure-specific instruments and accessories, service and maintenance contracts, digital workflow platforms, software, imaging integration, navigation capabilities, and other technologies directly supporting robot-assisted minimally invasive procedures. The market encompasses established multi-port robotic surgery platforms as well as single-port systems, compact and modular robots, miniaturized systems, robotic orthopedic platforms, spine guidance systems, and collaborative technologies designed to augment conventional laparoscopy.

The scale of the U.S. healthcare infrastructure provides an unusually large commercialization base. The country has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and roughly 35.7 million annual hospital admissions. In parallel, the ambulatory sector has expanded significantly. Medicare-certified ambulatory surgical centers reached more than 6,300 facilities, creating an increasingly important addressable market for compact robotic platforms with lower space requirements, faster setup, flexible financing structures, and procedure economics compatible with outpatient reimbursement.

Demographic and disease trends reinforce long-term procedure demand. Approximately 61.2 million Americans were aged 65 or older in 2024, equivalent to about 18% of the U.S. population. Older patients generate significant demand across cancer surgery, joint replacement, pelvic surgery, hernia repair, colorectal procedures, thoracic procedures, and other surgical categories in which minimally invasive techniques can reduce physiological stress and recovery burden.

Obesity also expands demand for robot-assisted surgical workflows. Approximately 40.3% of U.S. adults have obesity, while severe obesity approaches one in ten adults. This has direct implications for bariatric surgery and also affects procedural complexity across colorectal, gynecological, urological, hernia, and general surgical procedures.

Cancer is another important demand driver. The United States was expected to record approximately 313,780 new prostate cancer cases in 2025, while colorectal cancer was expected to account for more than 154,000 new diagnoses. Prostatectomy has historically represented one of the strongest robotic penetration categories, while colorectal, kidney, gynecologic, and thoracic oncology continue to expand the addressable procedure pool.

The strategic direction from 2026 through 2035 will increasingly involve moving from robot ownership toward robotic program economics. Hospital executives will ask how many procedures a platform can support, how quickly surgeons can be trained, what percentage of cases can be converted from open surgery, whether room turnover can improve, whether an existing instrument portfolio can be used, how much incremental staffing is required, and whether the robot can support cases in hospital outpatient departments or ASCs.

 

Key Market Drivers: What’s Fueling the U.S. Robot-Assisted Minimally Invasive Surgery Market Boom?

The first major market driver is the continued conversion of open and conventional laparoscopic procedures toward robot-assisted minimally invasive techniques. Robotics has already achieved deep penetration in prostate surgery and is increasingly important in hysterectomy, hernia repair, colorectal surgery, bariatric procedures, cholecystectomy, thoracic surgery, nephrectomy, partial nephrectomy, and complex general surgery. As clinical familiarity rises, surgeons are using robotics across increasingly complex anatomies and patient populations.

General surgery represents one of the most important growth engines. U.S. robotic general surgery procedure growth reached approximately 18% in 2025 on the leading installed platform. Hernia repair, colorectal procedures, bariatric surgery, cholecystectomy, and foregut surgery collectively represent a procedure pool significantly larger than the historic prostatectomy market. This expansion changes the economics of robotic systems because high-frequency general surgery cases can drive materially higher system utilization and recurring instrument revenue.

The second driver is the growing U.S. population requiring surgery. Adults aged 65 and older reached approximately 61.2 million in 2024 and are increasing faster than the population as a whole. Older patients experience higher rates of cancer, degenerative musculoskeletal disease, pelvic floor disorders, gallbladder disease, hernias, and other conditions that may require surgical intervention. Minimally invasive approaches are particularly attractive where reducing surgical trauma and accelerating recovery can improve discharge planning and patient experience.

The third major driver is hospital capital replacement and fleet expansion. Robotic surgery systems are increasingly managed as enterprise assets rather than isolated purchases. Large integrated delivery networks may operate fleets across flagship academic centers, community hospitals, outpatient departments, and specialty facilities. Procurement committees evaluate system utilization, procedural capacity, instrument economics, maintenance expenses, surgeon preference, training requirements, capital depreciation, and the strategic cost of losing surgeons or cases to competing health systems.

The fifth-generation technology cycle is materially accelerating this replacement opportunity. Hospitals that have operated robotic programs for a decade or longer are evaluating newer systems offering improved computing capability, ergonomic changes, force-sensing instruments, workflow integration, higher-quality visualization, digital telemetry, and greater potential for software-driven capabilities.

A fourth driver is competitive expansion. For much of the modern robotic surgery era, U.S. soft-tissue robotics was highly concentrated. That environment is changing. CMR Surgical received U.S. marketing authorization for Versius, Distalmotion received authorization for Dexter, Virtual Incision received authorization for MIRA, Moon Surgical has commercialized Maestro, and Medtronic received U.S. clearance for Hugo in urology in late 2025. Johnson & Johnson MedTech has also advanced OTTAVA through U.S. clinical development.

This increased platform choice has major implications for hospital purchasing behavior. Buyers can increasingly compare modular versus integrated architectures, open versus closed consoles, multi-port versus single-port designs, compact versus full-scale robots, purchasing versus leasing models, and procedure-specific versus multi-specialty systems. The resulting competition is expected to put pressure on capital pricing while simultaneously expanding the number of facilities economically capable of establishing robotic programs.

A fifth driver is migration toward ambulatory surgery. The United States already has more than 6,300 Medicare-certified ASCs, and selected general surgical, orthopedic, gynecologic, and urological procedures continue moving outside traditional inpatient operating rooms. Robotic systems historically faced barriers in ASCs because of acquisition cost, footprint, docking time, maintenance requirements, instrument cost, and uncertain utilization. New compact and modular architectures are directly targeting those constraints.

Inguinal hernia repair is particularly relevant. More than 90% of such procedures are already performed in outpatient or ambulatory environments. The growing availability of robotic systems designed around outpatient workflow can expand robot-assisted surgery beyond the largest hospitals and into facilities where conventional large-platform economics were previously difficult to justify.

A sixth driver is the relationship between robotics and surgeon recruitment. In competitive U.S. metropolitan markets, access to contemporary robotic technologies can influence surgeon affiliation, fellowship recruitment, referral capture, and patient perception. Health systems increasingly regard robotics as part of surgical service-line infrastructure in much the same way that advanced imaging, interventional suites, and hybrid operating rooms are strategic infrastructure.

Finally, reimbursement economics are forcing hospitals to become more disciplined about robotic utilization. For most procedures, the economic value of using a robot must be absorbed within the economics of the underlying surgical episode rather than depending on a broad incremental payment simply for robotic assistance. Platforms that improve throughput, reduce complications, increase minimally invasive conversion, shorten hospitalization, support outpatient migration, or enable greater utilization per capital unit are therefore likely to gain preference.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. robot-assisted minimally invasive surgery market is shifting from basic mechanical articulation toward integrated surgical intelligence. The first generation of competition centered on whether a robot could reproduce surgeon movements inside the body. The next generation is increasingly focused on what the system can sense, measure, standardize, predict, and document during a procedure.

Force feedback represents an important development. Traditional robotic surgery reduced direct tactile sensation, requiring surgeons to rely heavily on visual cues. Newer systems are introducing force-sensing instruments and feedback capabilities designed to provide additional information about tissue interaction. This may influence suturing, dissection, traction, and manipulation while also generating data that could eventually support training and procedural analytics.

Computing capacity is becoming another differentiator. Da Vinci 5, cleared in the United States in 2024, was designed with substantially greater computing power than earlier generations. The significance extends beyond faster processing. Higher computing capacity creates a foundation for future real-time analytics, enhanced sensing, automation assistance, workflow recognition, and AI-enabled decision support.

Single-port and miniaturized robotics are expanding the definition of minimally invasive surgery. Instead of relying on several large robotic arms positioned around the patient, newer systems can reduce external footprint or concentrate access through fewer entry points. Virtual Incision’s MIRA, for example, received U.S. De Novo authorization in 2024 as a miniaturized electromechanical surgical system. Such systems could create new economic and workflow models in procedure rooms, smaller operating suites, and outpatient facilities.

Modular robotics is also gaining strategic relevance. Platforms such as Versius, Dexter, and Hugo use architectures that differ materially from traditional fully integrated robotic systems. Modularity can enable surgical teams to configure robotic arms around procedure-specific requirements, potentially improve room flexibility, and avoid dedicating a complete operating room to a permanently configured platform.

Collaborative robotics represents another emerging category. Rather than replacing conventional laparoscopic workflow with a fully teleoperated robotic system, collaborative platforms can stabilize instruments, support exposure, enhance visualization, or assist the surgeon while preserving direct bedside interaction. Moon Surgical’s Maestro platform illustrates this direction and is particularly relevant to hospitals and ASCs seeking robotic augmentation without completely changing established laparoscopic workflow.

Digital connectivity will become a major source of competitive differentiation. Robotic systems increasingly generate detailed information about instrument movements, procedure duration, workflow steps, system utilization, surgeon performance patterns, video, and operational events. Hospitals can potentially use these data to improve credentialing, training, scheduling, utilization benchmarking, and quality programs.

Instrument innovation remains equally important. Robotic systems require reliable stapling, vessel sealing, grasping, clipping, suturing, energy delivery, and tissue manipulation. Manufacturers with extensive existing surgical instrument portfolios have an opportunity to integrate robotics into a broader operating-room ecosystem. This is particularly relevant to companies such as Medtronic and Johnson & Johnson MedTech, whose strategic value proposition can extend beyond the robotic console itself.

AI-assisted surgical capabilities are expected to develop gradually rather than through sudden autonomous surgery. Near-term commercialization is more likely to involve procedure recognition, instrument tracking, camera positioning, workflow guidance, performance analytics, anatomical awareness, automated documentation, and safety alerts. Increasing autonomy is likely to emerge task by task, with surgeons remaining responsible for clinical decision-making.

 

Segmentation Insights

The U.S. Robot-Assisted Minimally Invasive Surgery Market is segmented on the basis of component, surgical application, robotic technology type, end user, and region.

 

By Component

Robotic Surgical Systems

Robotic systems represent the principal capital-equipment component of the market. This category includes surgeon consoles, robotic arms, vision systems, carts, control electronics, patient-side units, integrated computing infrastructure, navigation units, and other reusable hardware. Capital revenue is influenced by new installations, replacement cycles, upgrades, operating leases, usage-based leasing, and expansion of robotic fleets within integrated health systems.

The arrival of fifth-generation systems and new competitors is creating a significant upgrade cycle. In 2025 alone, approximately 870 da Vinci 5 systems were placed globally. As new soft-tissue platforms enter the United States, hospitals will increasingly evaluate total ownership economics rather than relying only on capital purchase price.

Instruments and Accessories

Instruments and accessories represent the most strategically attractive recurring component because revenue scales directly with procedure utilization. Robotic scissors, graspers, needle drivers, staplers, vessel-sealing devices, trocars, drapes, cannulas, energy instruments, and other procedure-specific accessories generate repeated demand.

The economic significance is demonstrated by the leading market participant, which generated more than USD 6 billion in global instruments and accessories revenue during 2025. For U.S. hospital systems, this means the lifetime cost of a robotic program is determined substantially by case volume and per-procedure consumables rather than simply by the original robot acquisition.

Services and Maintenance

Service revenue includes preventive maintenance, system support, repairs, field service, upgrades, training support, and technical assistance. Hospitals performing large robotic case volumes require high system availability because unplanned downtime can disrupt OR schedules and surgeon productivity.

As robotic fleets become larger, procurement departments will increasingly negotiate enterprise-level maintenance arrangements. Service responsiveness can become a meaningful differentiator, especially for newer entrants attempting to compete with established nationwide support networks.

Software and Digital Surgical Workflow

Software and digital solutions represent a smaller current revenue category but are expected to record disproportionately strong growth. Applications include system software, surgical analytics, video management, training tools, remote collaboration, procedure insights, instrument tracking, utilization dashboards, AI-enabled assistance, and integration with broader hospital digital infrastructure.

By 2035, software may become one of the most important strategic layers in surgical robotics because it enables manufacturers to differentiate systems without replacing underlying hardware and creates the possibility of recurring subscription-style revenue.

 

By Surgical Application

General and Gastrointestinal Surgery

General and gastrointestinal surgery represents the largest incremental robotic procedure opportunity. Hernia repair, colorectal surgery, bariatric surgery, cholecystectomy, foregut surgery, and other abdominal procedures provide a high-volume pathway for expanding robotic utilization beyond traditional specialties.

U.S. robotic general surgery procedures on the leading installed platform grew approximately 18% during 2025. The attraction of this segment is not simply procedure volume. General surgeons often perform multiple types of operations, allowing health systems to spread fixed robotic capital costs across a larger number of cases.

Urology

Urology remains one of the most mature robotic surgery applications. Robot-assisted radical prostatectomy became an important foundation for the U.S. surgical robotics market and established many of the training, credentialing, and hospital investment models subsequently adopted by other specialties.

Demand remains supported by approximately 313,780 estimated new prostate cancer cases in the United States in 2025, along with kidney cancer, partial nephrectomy, cystectomy, pyeloplasty, and other complex minimally invasive urological procedures. The late-2025 U.S. clearance of Medtronic’s Hugo system for urologic procedures also creates a new competitive cycle in this established application.

Gynecology

Gynecologic surgery provides a large addressable market across hysterectomy, myomectomy, endometriosis procedures, pelvic reconstruction, sacrocolpopexy, and selected oncologic surgeries. Robotic articulation can be attractive in deep pelvic anatomy where conventional laparoscopy may be technically demanding.

Future growth is expected to come from both large hospital robotic programs and outpatient migration. Manufacturers designing systems for lower-acuity sites are targeting procedures such as benign hysterectomy and pelvic floor repair because of their volume and increasing suitability for same-day surgery.

Orthopedic and Spine Surgery

Orthopedic and spine robotic surgery contributes a distinct but significant market opportunity. Robotic systems used for knee and hip arthroplasty, spinal instrumentation, minimally invasive spine surgery, implant positioning, bone preparation, and image-guided navigation are increasingly embedded into procedure workflows.

Stryker’s Mako platform surpassed 2.5 million global procedures by 2025, demonstrating the scale that procedure-specific orthopedic robotics can achieve. Spine robotics is also expanding as health systems seek reproducible implant trajectories, improved surgical planning, and greater integration between imaging, navigation, and robotic guidance.

Cardiothoracic and Other Complex Minimally Invasive Procedures

Cardiothoracic, transoral, microsurgical, and other complex applications represent smaller but strategically important segments. Thoracic surgery is an established robotic application, particularly for pulmonary and mediastinal procedures.

The January 2026 expansion of da Vinci 5 into selected cardiac procedures provides another future growth pathway. Cardiac robotics remains operationally demanding, but mitral valve repair, internal mammary artery mobilization, and other selected procedures could become important premium applications as dedicated multidisciplinary programs gain experience.

 

By Robotic Technology Type

Multi-Port Teleoperated Robotic Systems

Multi-port teleoperated systems currently dominate the U.S. soft-tissue robotic surgery market. These platforms offer mature instrument ecosystems, extensive surgeon training infrastructure, broad indications, and large installed bases.

Their primary competitive advantage is procedural breadth. Large hospitals can spread capital costs across urology, gynecology, general surgery, thoracic surgery, and other specialties, making multi-port systems central to enterprise robotic programs.

Single-Port and Miniaturized Robotic Systems

Single-port and miniaturized systems are expected to record above-market growth because they address procedural access and facility-footprint limitations. They can be attractive for transoral, urological, colorectal, and other procedures where minimizing external arm congestion or access points is important.

Miniaturization may also materially change site-of-care economics by allowing robotic technologies to reach smaller ORs, outpatient environments, and facilities without the footprint required by conventional systems.

Modular and Open-Console Systems

Modular systems allow robotic arms and components to be positioned based on the surgical procedure rather than relying on one fixed architecture. Open consoles can also maintain direct visual interaction among operating-room personnel.

CMR Surgical, Distalmotion, and Medtronic are among the companies advancing differentiated modular approaches. This segment should benefit from hospitals seeking greater room flexibility and from buyers that want alternatives to legacy robotic configurations.

Robotic Orthopedic and Spine Guidance Systems

This category includes robotic-arm-assisted bone preparation, orthopedic planning, robotic navigation, spinal implant guidance, and related systems. Stryker, Zimmer Biomet, Smith+Nephew, Globus Medical, THINK Surgical, Brainlab, and other suppliers participate in different parts of the segment.

Growth is supported by high U.S. joint replacement volumes, aging demographics, implant competition, and the strategic importance of orthopedic service lines.

AI-Enhanced Collaborative and Assistive Robotics

Collaborative robotic systems are designed to augment rather than completely replicate surgical manipulation. They may stabilize instruments, control cameras, provide workflow assistance, or support specific surgical tasks.

AI-enhanced collaborative systems could become an important bridge between conventional laparoscopy and full robotic surgery, particularly in ASCs and community hospitals where economics and room efficiency are critical.

 

By End User

Large Hospitals and Integrated Delivery Networks

Large hospitals and IDNs represent the dominant end-user segment. These organizations frequently operate multiple robotic systems and have enough procedure volume to support enterprise contracts, specialty allocation, centralized training, and sophisticated utilization analytics.

Large IDNs are increasingly negotiating capital equipment, service, instruments, training, and digital capabilities as an integrated commercial relationship. This gives manufacturers with broad portfolios an important competitive advantage.

Academic and Tertiary Medical Centers

Academic medical centers are important early adopters because they conduct clinical trials, train surgeons, develop robotic procedural protocols, and treat complex referral cases. New systems frequently enter the U.S. through leading academic institutions where evidence can be generated before broader community expansion.

These centers are particularly influential in complex urology, bariatrics, thoracic surgery, colorectal surgery, surgical oncology, cardiac robotics, and new robotic applications.

Community Hospitals

Community hospitals represent a substantial next phase of penetration. Many already perform significant laparoscopic surgical volumes but cannot economically justify the number or scale of robotic systems used by major academic centers.

Flexible financing, smaller footprints, simplified training, and multi-specialty utilization will be important for companies seeking to penetrate this customer segment.

Ambulatory Surgery Centers and Hospital Outpatient Departments

ASCs and hospital outpatient departments are expected to be among the fastest-growing end-user categories. The United States has more than 6,300 Medicare-certified ASCs, providing a large potential deployment base.

Successful ASC-focused robots must address different economics from inpatient hospitals. Lower capital requirements, predictable disposable costs, small footprints, rapid setup, limited reprocessing burden, portability, and minimal additional staffing will be critical.

Specialty Surgical Hospitals and Centers

Orthopedic hospitals, women’s health centers, urology centers, surgical oncology facilities, and other specialty providers can support high utilization where procedure concentration is sufficient. Procedure-specific robotics may be particularly attractive because technology investments can reinforce a facility’s clinical differentiation and referral positioning.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Robot-Assisted Minimally Invasive Surgery Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand differs substantially according to population growth, age distribution, hospital density, surgical procedure volumes, academic center concentration, ASC development, health-system consolidation, surgeon availability, payer mix, and technology adoption.

The South is estimated to represent the largest regional market in 2025, while the West is projected to post the fastest growth through 2035. The Northeast will remain important for complex procedures and early clinical adoption, while the Midwest will provide a large, stable base of orthopedic, general surgery, urology, and integrated health-system demand.

South

The South represents an estimated USD 3.05 billion market in 2025 and is projected to approach USD 12.55 billion by 2035, representing growth of approximately 15.2% annually. The region includes Texas, Florida, Georgia, North Carolina, Tennessee, South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, and West Virginia.

Texas is one of the most strategically important state markets in the country. Houston, Dallas-Fort Worth, Austin, and San Antonio support large academic hospitals, integrated networks, bariatric programs, urology practices, orthopedic centers, and surgical innovation programs. The state is also serving as a development location for next-generation robotics: the first clinical cases for Johnson & Johnson MedTech’s OTTAVA platform were performed in Houston in 2025.

Texas has additionally been important to newer entrants. Memorial Hermann became an early U.S. purchaser of the Dexter robotic system, illustrating how large health systems may eventually maintain multiple robotic architectures depending on procedure and facility requirements.

Florida is another major regional market because of its population scale, high concentration of older adults, growing hospital networks, orthopedic procedure demand, and extensive ambulatory surgery infrastructure. Large health systems across Florida are expanding outpatient procedural capacity, creating favorable conditions for compact and flexible robotics. AdventHealth has been an early U.S. adopter of newer outpatient-oriented robotic technologies, underscoring the state’s importance for next-generation deployment.

North Carolina combines large academic institutions, integrated provider networks, research programs, and population growth. The state has played an important role in initial commercialization of newer robotic systems and is likely to remain a high-value market for clinical evidence generation.

Georgia and Tennessee are attractive because of strong metropolitan growth around Atlanta and Nashville, expanding surgical networks, and the presence of large healthcare organizations. Virginia and Maryland benefit from sophisticated academic providers, dense specialist networks, strong commercial insurance markets, and proximity to federal research institutions.

South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia provide smaller individual markets but collectively represent a significant opportunity. Obesity, chronic disease, cancer burden, and access disparities create demand for minimally invasive procedures, while fewer high-volume robotic centers in some communities create an opportunity for scalable systems capable of operating outside major academic institutions.

The South’s long-term advantage comes from population migration, greenfield hospital construction, expansion of outpatient surgical networks, and relatively strong growth in high-volume metropolitan markets. As health systems compete for surgeons and commercially insured patients, access to robotics will remain strategically important.

West

The West is estimated at approximately USD 2.01 billion in 2025 and is projected to reach around USD 9.10 billion by 2035, representing an estimated 16.3% CAGR, the fastest regional growth rate in the report. The region comprises California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the single most influential technology-development state for U.S. surgical robotics. It is home to Intuitive Surgical and numerous medtech, AI, imaging, semiconductor, software, and venture-capital ecosystems that support surgical technology development. California also has major academic providers capable of participating in clinical trials and adopting emerging platforms.

The state’s combination of technology expertise and large surgical procedure volumes makes it strategically important for robotic data platforms, AI-assisted surgery, new instrument development, and system commercialization. UC San Diego Health, for example, performed the first U.S. outpatient procedures with Dexter shortly after its 2024 authorization.

Arizona and Nevada are high-growth markets because of population expansion, retirement migration, and increasing investment in hospitals and outpatient surgical facilities. Both states are attractive for joint replacement, urology, general surgery, and bariatric robotic procedures.

Washington and Oregon have sophisticated integrated health systems that place strong emphasis on evidence, workflow economics, and digital integration. These markets may be particularly receptive to technologies that can demonstrate measurable reductions in variation or improve surgical utilization.

Colorado and Utah combine growing populations with advanced referral centers and strong technology-oriented provider networks. Utah in particular has a favorable environment for value-conscious healthcare innovation, while Colorado supports significant orthopedic and specialty surgical demand.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets where geography can limit access to complex surgical care. Compact robotic technologies could be strategically relevant when they enable advanced minimally invasive capabilities within regional centers and reduce the need for patients to travel long distances to major metropolitan hospitals.

The West should gain market share over the forecast period because it combines high clinical innovation intensity with strong technology infrastructure and comparatively rapid adoption of AI, data-enabled surgical workflow, compact robotics, and ambulatory care models.

Northeast

The Northeast is estimated at approximately USD 2.05 billion in 2025 and is projected to reach about USD 8.20 billion by 2035, representing an estimated 14.9% CAGR. The regional model includes New York, Pennsylvania, Massachusetts, New Jersey, Connecticut, Maine, Vermont, New Hampshire, Rhode Island, and Delaware.

New York provides one of the country’s largest concentrations of hospitals, surgeons, academic institutions, and ambulatory facilities. Major health systems perform high volumes of urology, gynecology, general surgery, colorectal surgery, oncology, and orthopedic procedures suitable for robotic assistance.

The Buffalo market has also emerged as an early example of outpatient robotic adoption, with an ASC acquiring Dexter in 2025. Such deployments are strategically important because they test whether surgical robotics can achieve sustainable economics in independent or joint-venture outpatient facilities.

Massachusetts remains disproportionately important relative to its population because of its concentration of globally influential teaching hospitals, surgical research centers, and technology development organizations. New robotic platforms seeking clinical validation, evidence generation, and physician advocacy frequently prioritize these types of institutions.

Pennsylvania and New Jersey provide substantial procedure volumes across academic, integrated, and community hospitals. Pennsylvania is especially important for large health systems serving both metropolitan and regional populations. New Jersey benefits from dense population, strong commercial payer presence, proximity to major medtech organizations, and access to surgeons working across the New York metropolitan area.

Connecticut, Rhode Island, New Hampshire, Maine, Vermont, and Delaware contribute smaller markets but have meaningful opportunities in large integrated networks and regional specialty programs. Aging populations in several New England states strengthen demand for cancer surgery, joint replacement, and other minimally invasive procedures.

Growth in the Northeast will be slightly slower than in the West because robotic penetration is already comparatively mature. However, revenue per hospital and procedure complexity remain attractive. Replacement of older systems, adoption of fifth-generation platforms, competitive second-platform purchases, and increased outpatient use should continue supporting significant market expansion.

Midwest

The Midwest represents an estimated USD 1.63 billion market in 2025 and is projected to reach approximately USD 6.12 billion by 2035, equivalent to an estimated 14.1% CAGR. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest regional opportunity because of the concentration of hospitals and specialist practices in the Chicago metropolitan area. Major health systems support significant robotic procedure volumes across general surgery, urology, gynecology, thoracic surgery, oncology, orthopedics, and spine.

Ohio is strategically important because of high surgical capacity and globally recognized tertiary centers. Cleveland Clinic performed the first U.S. commercial procedure with Medtronic’s Hugo system in February 2026, highlighting Ohio’s role as an early-adoption and clinical-validation market.

Minnesota is uniquely important because of its medical technology ecosystem and major referral institutions. The state has deep expertise in surgical technology, orthopedics, cardiovascular devices, and healthcare innovation, making it influential in procurement and clinical evidence development.

Michigan, Indiana, Wisconsin, and Missouri provide large and stable procedure volumes across community and academic hospital systems. These states are particularly relevant for robotic joint replacement, spine surgery, general surgery, and urology.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller populations but significant regional referral networks. Compact robotic systems and hub-and-spoke clinical models could help expand access to minimally invasive capabilities where maintaining multiple traditional high-cost platforms may not be economical.

The Midwest is expected to remain a comparatively value-conscious market. Manufacturers that can demonstrate service reliability, predictable operating costs, high system utilization, enterprise contracting flexibility, and strong clinical training support are likely to perform particularly well.

 

Key Market Players

The competitive landscape of the U.S. Robot-Assisted Minimally Invasive Surgery Market is transitioning from a market dominated by one large soft-tissue ecosystem into a broader competitive environment with multiple robotic architectures.

Intuitive Surgical remains the dominant U.S. soft-tissue robotic surgery company because of its large installed base, procedural breadth, extensive surgeon training ecosystem, recurring instrument revenue, service infrastructure, and fifth-generation da Vinci platform.

Medtronic has become increasingly important following U.S. clearance of Hugo for urologic surgery in December 2025. Its competitive advantage is the ability to combine robotics with a major portfolio of conventional surgical instruments, energy products, stapling, meshes, digital technologies, and operating-room relationships.

Johnson & Johnson MedTech is developing OTTAVA and brings significant Ethicon surgical instrument expertise, hospital relationships, and financial capacity. Successful commercialization would materially intensify competition in multi-specialty soft-tissue robotics.

Other strategically relevant market participants and emerging competitors include Stryker, Zimmer Biomet, Smith+Nephew, Globus Medical, CMR Surgical, Distalmotion, Virtual Incision, Moon Surgical, KARL STORZ/Asensus Surgical, THINK Surgical, PROCEPT BioRobotics, Momentis Surgical, Medical Microinstruments, Vicarious Surgical, EndoQuest Robotics, Noah Medical, Brainlab, Renishaw, and Corin Group.

Stryker is particularly important in orthopedic robotics through Mako, while Zimmer Biomet, Smith+Nephew, THINK Surgical, and other suppliers compete across robotic joint reconstruction. Globus Medical has built a significant position in spine robotics and navigation.

CMR Surgical, Distalmotion, Virtual Incision, and Moon Surgical represent a new generation of companies attempting to change the cost, footprint, portability, and workflow assumptions associated with surgical robotics.

Competition through 2035 will increasingly depend on five factors: procedural breadth, total procedure cost, installed-base utilization, quality of the instrument ecosystem, and ability to convert system-generated data into measurable clinical and operational value.

The traditional razor-and-blade model will remain important, but business models will diversify. Capital sales will increasingly coexist with operating leases, usage-based arrangements, strategic placements, enterprise contracts, instrument commitments, and software subscriptions. This will make headline system price an increasingly incomplete indicator of competitive positioning.

 

Recent Developments

The U.S. robot-assisted minimally invasive surgery market entered a major technology transition beginning in 2024. In March 2024, the FDA cleared Intuitive Surgical’s da Vinci 5, beginning the commercial transition to a fifth-generation multi-port system. The system introduced a higher-compute architecture and new capabilities intended to support improved surgical interaction and future software development.

In February 2024, Virtual Incision received FDA De Novo authorization for the MIRA Surgical System, establishing a regulatory pathway for miniaturized robotic surgery. The development was strategically important because it demonstrated that commercially relevant surgical robotics does not necessarily require a conventional large robotic architecture.

In June 2024, Moon Surgical received additional FDA clearance covering the commercial version of its Maestro system. Maestro represents a collaborative robotic approach designed to augment conventional laparoscopy rather than fully replace it.

In October 2024, CMR Surgical received U.S. FDA marketing authorization through the De Novo pathway for the Versius Surgical System, initially for cholecystectomy. Versius had already been used in more than 26,000 procedures internationally at the time of U.S. authorization, giving the company meaningful global clinical experience before broader American commercialization.

Also in October 2024, Distalmotion received U.S. De Novo marketing authorization for the Dexter Robotic Surgery System for adult inguinal hernia repair. The first U.S. patients were treated in an outpatient environment the following month, illustrating the growing importance of ASC-oriented surgical robotics.

During 2025, Distalmotion expanded commercial placements, including a first U.S. sale to Memorial Hermann and adoption by an ambulatory surgery center. These milestones are strategically relevant because they demonstrate that new entrants are targeting not only flagship academic hospitals but also outpatient environments.

In April 2025, Johnson & Johnson MedTech announced completion of the first clinical cases with its investigational OTTAVA Robotic Surgical System, beginning with Roux-en-Y gastric bypass procedures in Houston. The study supports J&J’s attempt to enter soft-tissue robotics with a table-integrated robotic architecture and an instrument ecosystem connected to its broader surgery franchise.

During 2025, adoption of Intuitive’s newest platform accelerated substantially. The company placed 1,721 da Vinci systems during the year, including 870 da Vinci 5 systems, while worldwide da Vinci procedures exceeded 3.15 million. The company ended 2025 with approximately 11,106 da Vinci systems installed globally.

In December 2025, Medtronic received FDA clearance for the Hugo robotic-assisted surgery system for urologic procedures, bringing another large global medtech company into the commercial U.S. soft-tissue robotic market.

In February 2026, the first U.S. commercial Hugo procedure was performed at Cleveland Clinic. Medtronic subsequently submitted filings in 2026 seeking to expand Hugo into general and gynecologic surgery, which could materially broaden its U.S. addressable market if cleared.

In January 2026, da Vinci 5 received FDA clearance for selected cardiac procedures, including mitral valve procedures and internal mammary artery mobilization for cardiac revascularization. The development expands the potential role of next-generation robotics in one of the most operationally complex areas of minimally invasive surgery.

These developments demonstrate that the U.S. market is entering a structurally different competitive cycle. The strategic question is shifting from whether robotic surgery will continue expanding to which platform architectures will gain share, which specialties will convert most rapidly, and whether hospitals will standardize on single ecosystems or adopt multi-vendor robotic fleets.

 

Conclusion

The U.S. Robot-Assisted Minimally Invasive Surgery Market Size & Share is projected to expand from approximately USD 8.74 billion in 2025 to USD 35.97 billion by 2035, representing a 15.20% CAGR during 2026–2035. The market’s growth is supported by rising robotic procedure penetration, an aging population, high surgical disease burden, replacement of earlier robotic systems, growing general surgery adoption, competitive platform introductions, and increasing interest in outpatient robotic workflows.

The market is entering an important transition from first-generation robotic adoption to robotic surgical infrastructure optimization. Large hospitals are moving toward multi-system fleets and enterprise procurement, while community hospitals and ambulatory facilities are becoming increasingly accessible to compact, modular, miniaturized, and collaborative platforms.

Recurring instruments and accessories will remain central to industry profitability. The most commercially attractive robotic systems will therefore be those that combine high procedural throughput with broad instrument portfolios, dependable service, efficient room utilization, and training models that allow hospitals to scale robotic programs without disproportionate operating complexity.

General and gastrointestinal surgery will provide one of the largest incremental procedure pools, while urology will remain a mature high-penetration category. Gynecology will benefit from outpatient migration, orthopedic and spine robotics will continue expanding through procedure-specific platforms, and cardiothoracic applications will provide selective premium opportunities.

Regionally, the South is expected to remain the largest market, supported by Texas, Florida, North Carolina, Georgia, Tennessee, and other rapidly growing states. The West is expected to record the fastest growth, with California remaining central to technology development and early adoption. The Northeast will remain highly important for complex surgery and evidence generation, while the Midwest will offer a stable, economically disciplined market with strong orthopedic, spine, urology, and general surgery demand.

For manufacturers, hospital executives, investors, distributors, and strategic buyers evaluating this market, the key issue is no longer simply the number of robotic systems placed. The most valuable indicator will be the economic productivity of each installed system: procedures per robot, recurring revenue per procedure, incremental minimally invasive conversion, surgeon adoption, service reliability, outpatient compatibility, and measurable impact on the total surgical episode.

The companies most likely to gain share through 2035 will be those capable of combining robotic precision, high-utilization procedure economics, flexible commercial models, clinically differentiated instruments, scalable surgeon training, digital workflow integration, and credible evidence of clinical and operational value. Surgical robotics is therefore evolving from a premium capital-equipment category into an increasingly integrated operating-room technology platform—and that transition will define the next decade of the U.S. robot-assisted minimally invasive surgery industry.

 

TABLE OF CONTENT

1. U.S. Robot-Assisted Minimally Invasive Surgery Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Surgical Robotic System Manufacturers
1.6.2. Robotic Instruments, Accessories and Component Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Academic Medical Centers and Specialty Surgical Centers
1.6.5. Ambulatory Surgery Centers and Hospital Outpatient Departments
1.6.6. Surgeons, Clinical Training Organizations and Robotic Program Administrators
1.6.7. Group Purchasing Organizations and Distribution Partners
1.6.8. Payers, FDA, CMS and Clinical Decision-Makers

What this section provides: This section defines the market boundary, study scope, methodology, assumptions, and stakeholder ecosystem used to measure and validate the U.S. robot-assisted minimally invasive surgery market.

2. U.S. Robot-Assisted Minimally Invasive Surgery Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025 vs. 2035
2.8. Robotic Procedure Volume Outlook
2.9. Installed Base and Replacement Cycle Outlook
2.10. High-Growth Opportunity Areas
2.11. Key Investment and Procurement Themes

What this section provides: This section gives decision-makers a concise view of market size, growth trajectory, robotic procedure adoption, installed-base development, high-growth applications, competitive intensity, and priority investment opportunities.

3. U.S. Robot-Assisted Minimally Invasive Surgery Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Increasing Conversion from Open Surgery to Minimally Invasive Surgery
3.1.2. Rapid Growth of Robot-Assisted General Surgery Procedures
3.1.3. Expanding Urology, Gynecology and Colorectal Robotic Procedure Volumes
3.1.4. Aging U.S. Population and Increasing Surgical Disease Burden
3.1.5. Hospital Robotic Fleet Expansion and Replacement Cycles
3.1.6. Surgeon Recruitment, Training and Robotic Credentialing
3.1.7. Expansion of Ambulatory and Outpatient Robotic Surgery
3.1.8. Growing Competition Among Surgical Robotic Platforms

3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Acquisition and Lifecycle Costs
3.2.2. Recurring Instrument and Accessory Expense
3.2.3. Limited Incremental Reimbursement for Robotic Assistance
3.2.4. Operating Room Setup, Docking and Workflow Complexity
3.2.5. Surgeon Learning Curve and Training Requirements
3.2.6. Capital Budget Competition within U.S. Health Systems

3.3. Opportunities and Their Impact Analysis
3.3.1. Fifth-Generation Robotic Platform Replacement
3.3.2. Single-Port and Miniaturized Robotic Surgery
3.3.3. Modular and Open-Console Robotic Architectures
3.3.4. ASC-Compatible Surgical Robotic Systems
3.3.5. AI-Enabled Surgical Workflow and Procedure Analytics
3.3.6. Force-Sensing and Haptic-Assisted Technologies
3.3.7. Expansion into Cardiac, Thoracic and Complex MIS Procedures
3.3.8. Robotic Orthopedic and Spine Surgery Expansion

3.4. Challenges and Their Impact Analysis
3.4.1. Demonstrating Incremental Clinical Value Versus Conventional Laparoscopy
3.4.2. Maintaining High Procedure Utilization per Installed System
3.4.3. Multi-Vendor Robotic Fleet Management
3.4.4. Cybersecurity and Connected OR Risks
3.4.5. Robotic System Service and Downtime Management

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Robotic Procedure Adoption Curve Analysis
3.7. Clinical Workflow Economics Analysis
3.8. Hospital Capital Procurement Behavior Analysis
3.9. Total Cost per Robotic Procedure Analysis
3.10. Surgeon Training and Credentialing Landscape
3.11. Robotic System Replacement Cycle Analysis
3.12. Hospital vs. ASC Robotic Surgery Economics

What this section provides: This section explains the clinical, economic, technological, reimbursement, and procurement forces shaping robotic surgery adoption and helps clients identify scalable opportunities and execution risks.

4. U.S. Robot-Assisted Minimally Invasive Surgery Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital and ASC Buyers
4.2.3. Bargaining Power of Component and Instrument Suppliers
4.2.4. Substitution Risk from Open and Conventional Laparoscopic Surgery
4.2.5. Competitive Rivalry

4.3. Surgical Robotic System Pricing Trend Analysis, 2025–2035
4.4. Instruments and Accessories Pricing Trend Analysis
4.5. Value Chain & Supply Chain Analysis
4.6. Capital Equipment Leasing and Usage-Based Business Models
4.7. Surgical Robot Installed Base Analysis
4.8. Robotic Procedure Utilization Analysis
4.9. Robotic Operating Room Workflow Analysis
4.10. Impact of Digitalization and Connected Operating Rooms
4.11. AI and Surgical Data Analytics Landscape
4.12. Application & Innovation Landscape
4.13. FDA Regulatory Framework Analysis
4.14. CMS Reimbursement and Coverage Landscape
4.15. Robotic Surgery Coding and Payment Considerations
4.16. Import/Export Restrictions & Tariff Impact
4.17. Supply Chain and Critical Component Dependency Analysis
4.18. Cybersecurity and Medical Device Connectivity Requirements
4.19. Hospital Value Analysis Committee Decision Framework
4.20. Robotic Platform Purchase vs. Lease Decision Analysis

What this section provides: This section provides a complete assessment of the regulatory, reimbursement, pricing, technological, supply-chain, purchasing, and operating environment affecting surgical robotic commercialization in the United States.

5. U.S. Robot-Assisted Minimally Invasive Surgery Market – By Component

5.1. Overview
5.1.1. Segment Share Analysis, By Component, 2025 & 2035 (%)
5.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)

5.2. Robotic Surgical Systems
5.2.1. Multi-Arm Robotic Platforms
5.2.2. Compact and Miniaturized Robotic Systems
5.2.3. Procedure-Specific Robotic Platforms
5.2.4. Robotic Consoles and Patient-Side Systems
5.2.5. Vision and Imaging Modules

5.3. Instruments and Accessories
5.3.1. Robotic Graspers and Forceps
5.3.2. Needle Drivers and Suturing Instruments
5.3.3. Robotic Stapling Systems
5.3.4. Energy and Vessel-Sealing Instruments
5.3.5. Scissors and Dissection Instruments
5.3.6. Trocars, Cannulas and Access Devices
5.3.7. Drapes and Procedure-Specific Accessories

5.4. Services and Maintenance
5.4.1. Preventive Maintenance
5.4.2. Technical and Field Service
5.4.3. System Upgrade Services
5.4.4. Surgeon and Staff Training Support

5.5. Software and Digital Surgical Workflow
5.5.1. Surgical Analytics Software
5.5.2. Robotic Procedure Data Platforms
5.5.3. Video Management and Surgical Intelligence
5.5.4. Remote Collaboration and Tele-Mentoring
5.5.5. AI-Enabled Workflow Assistance

What this section provides: This section identifies how capital systems, recurring instruments, accessories, services, and software contribute to market revenue and highlights the components expected to generate the strongest recurring value through 2035.

6. U.S. Robot-Assisted Minimally Invasive Surgery Market – By Surgical Application

6.1. Overview
6.1.1. Segment Share Analysis, By Surgical Application, 2025 & 2035 (%)
6.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)

6.2. General and Gastrointestinal Surgery
6.2.1. Hernia Repair
6.2.2. Cholecystectomy
6.2.3. Colorectal Surgery
6.2.4. Bariatric Surgery
6.2.5. Foregut Surgery
6.2.6. Other General Surgical Procedures

6.3. Urology
6.3.1. Radical Prostatectomy
6.3.2. Partial Nephrectomy
6.3.3. Radical Nephrectomy
6.3.4. Cystectomy
6.3.5. Pyeloplasty
6.3.6. Other Urological Procedures

6.4. Gynecology
6.4.1. Hysterectomy
6.4.2. Myomectomy
6.4.3. Endometriosis Surgery
6.4.4. Sacrocolpopexy and Pelvic Reconstruction
6.4.5. Gynecologic Oncology Procedures
6.4.6. Other Gynecologic Procedures

6.5. Orthopedic and Spine Surgery
6.5.1. Total Knee Arthroplasty
6.5.2. Partial Knee Arthroplasty
6.5.3. Total Hip Arthroplasty
6.5.4. Spinal Instrumentation and Fusion
6.5.5. Minimally Invasive Spine Surgery
6.5.6. Other Orthopedic Procedures

6.6. Cardiothoracic and Other Complex MIS Procedures
6.6.1. Thoracic Surgery
6.6.2. Lung Resection Procedures
6.6.3. Mitral Valve Procedures
6.6.4. Robotic Cardiac Revascularization Procedures
6.6.5. Transoral Robotic Surgery
6.6.6. Microsurgical and Other Emerging Applications

What this section provides: This section evaluates robotic surgery demand across major clinical specialties and helps clients identify high-volume, high-growth, and emerging procedural opportunities.

7. U.S. Robot-Assisted Minimally Invasive Surgery Market – By Robotic Technology Type

7.1. Overview
7.1.1. Segment Share Analysis, By Robotic Technology Type, 2025 & 2035 (%)
7.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)

7.2. Multi-Port Teleoperated Robotic Systems
7.2.1. Integrated Multi-Arm Platforms
7.2.2. Surgeon Console-Based Systems

7.3. Single-Port and Miniaturized Robotic Systems
7.3.1. Single-Incision Robotic Platforms
7.3.2. Intracorporeal and Miniaturized Systems

7.4. Modular and Open-Console Robotic Systems
7.4.1. Independent Robotic Arm Platforms
7.4.2. Open-Console Surgical Systems
7.4.3. Hybrid Laparoscopic-Robotic Platforms

7.5. Robotic Orthopedic and Spine Guidance Systems
7.5.1. Robotic-Arm-Assisted Joint Replacement Systems
7.5.2. Robotic Spine Guidance Systems
7.5.3. Robotic Navigation and Implant Placement Systems

7.6. AI-Enhanced Collaborative and Assistive Robotics
7.6.1. Collaborative Surgical Robotics
7.6.2. Robotic Camera and Instrument Assistance
7.6.3. AI-Assisted Surgical Guidance
7.6.4. Semi-Autonomous Task Assistance

What this section provides: This section analyzes the competing robotic architectures shaping the market and highlights how multi-port, single-port, modular, orthopedic, collaborative, and AI-enabled systems are likely to evolve through 2035.

8. U.S. Robot-Assisted Minimally Invasive Surgery Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)

8.2. Large Hospitals and Integrated Delivery Networks
8.2.1. Multi-Hospital Robotic Programs
8.2.2. Enterprise Robotic Fleet Procurement

8.3. Academic and Tertiary Medical Centers
8.3.1. Teaching Hospitals
8.3.2. Clinical Trial and Robotic Innovation Centers

8.4. Community Hospitals
8.4.1. Regional Referral Hospitals
8.4.2. Independent Community Hospitals

8.5. Ambulatory Surgery Centers and Hospital Outpatient Departments
8.5.1. Independent ASCs
8.5.2. Hospital-Owned ASCs
8.5.3. Physician-Hospital Joint Venture ASCs
8.5.4. Hospital Outpatient Surgical Departments

8.6. Specialty Surgical Hospitals and Centers
8.6.1. Orthopedic Surgical Centers
8.6.2. Urology Centers
8.6.3. Women’s Health and Gynecology Centers
8.6.4. Surgical Oncology Centers
8.6.5. Other Specialty Surgical Facilities

What this section provides: This section identifies the customer groups driving robotic system acquisition, procedure utilization, replacement demand, recurring instrument consumption, and outpatient adoption.

9. U.S. Robot-Assisted Minimally Invasive Surgery Market – By Geography

9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
9.1.3. Regional Robotic Procedure Volume Analysis
9.1.4. Regional Surgical Robot Installed Base Analysis
9.1.5. Hospital and ASC Infrastructure Analysis
9.1.6. Regional Capital Procurement and Leasing Dynamics
9.1.7. Regional Surgeon Availability and Training Ecosystem
9.1.8. Robotic Surgery Adoption Hotspot Analysis

9.2. West Region

9.2.1. Regional Overview & Trends
9.2.2. West Region Surgical Robotics Manufacturers and Procurement Ecosystem
9.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.2.4. West Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.5. West Region Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.6. West Region Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.8. West Region Robotic Procedure Volume, Installed Base and ASC Adoption Outlook

9.2.9. California
9.2.9.1. Overview
9.2.9.2. California Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.9.3. California Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.9.4. California Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.9.6. California Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.10. Washington
9.2.10.1. Overview
9.2.10.2. Washington Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.10.3. Washington Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.10.4. Washington Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.10.6. Washington Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.11. Arizona
9.2.11.1. Overview
9.2.11.2. Arizona Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.11.3. Arizona Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.11.4. Arizona Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.11.6. Arizona Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.12. Colorado
9.2.12.1. Overview
9.2.12.2. Colorado Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.12.3. Colorado Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.12.4. Colorado Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.12.6. Colorado Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.13. Oregon
9.2.13.1. Overview
9.2.13.2. Oregon Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.13.3. Oregon Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.13.4. Oregon Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.13.6. Oregon Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.14. Utah
9.2.14.1. Overview
9.2.14.2. Utah Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.14.3. Utah Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.14.4. Utah Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.14.6. Utah Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.15. Nevada
9.2.15.1. Overview
9.2.15.2. Nevada Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.15.3. Nevada Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.15.4. Nevada Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.15.6. Nevada Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.16. New Mexico
9.2.16.1. Overview
9.2.16.2. New Mexico Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.16.3. New Mexico Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.16.4. New Mexico Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.16.6. New Mexico Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.17. Idaho
9.2.17.1. Overview
9.2.17.2. Idaho Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.17.3. Idaho Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.17.4. Idaho Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.17.6. Idaho Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.18. Montana
9.2.18.1. Overview
9.2.18.2. Montana Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.18.3. Montana Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.18.4. Montana Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.18.6. Montana Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.19. Wyoming
9.2.19.1. Overview
9.2.19.2. Wyoming Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.19.3. Wyoming Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.19.4. Wyoming Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.19.6. Wyoming Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.20. Alaska
9.2.20.1. Overview
9.2.20.2. Alaska Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.20.3. Alaska Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.20.4. Alaska Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.20.6. Alaska Robotic Procedure Volume, Installed Base and Adoption Outlook

9.2.21. Hawaii
9.2.21.1. Overview
9.2.21.2. Hawaii Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.21.3. Hawaii Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.2.21.4. Hawaii Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.21.6. Hawaii Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3. Northeast Region

9.3.1. Regional Overview & Trends
9.3.2. Northeast Region Surgical Robotics Manufacturers and Procurement Ecosystem
9.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.3.4. Northeast Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.5. Northeast Region Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.6. Northeast Region Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.8. Northeast Region Robotic Procedure Volume, Installed Base and ASC Adoption Outlook

9.3.9. New York
9.3.9.1. Overview
9.3.9.2. New York Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.9.3. New York Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.9.4. New York Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.9.6. New York Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3.10. Massachusetts
9.3.10.1. Overview
9.3.10.2. Massachusetts Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.10.3. Massachusetts Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.10.4. Massachusetts Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.10.6. Massachusetts Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3.11. New Jersey
9.3.11.1. Overview
9.3.11.2. New Jersey Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.11.3. New Jersey Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.11.4. New Jersey Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.11.6. New Jersey Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3.12. Pennsylvania
9.3.12.1. Overview
9.3.12.2. Pennsylvania Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.12.3. Pennsylvania Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.12.4. Pennsylvania Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.12.6. Pennsylvania Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3.13. Connecticut
9.3.13.1. Overview
9.3.13.2. Connecticut Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.13.3. Connecticut Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.13.4. Connecticut Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.13.6. Connecticut Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3.14. Maine
9.3.14.1. Overview
9.3.14.2. Maine Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.14.3. Maine Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.14.4. Maine Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.14.6. Maine Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3.15. Vermont
9.3.15.1. Overview
9.3.15.2. Vermont Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.15.3. Vermont Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.15.4. Vermont Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.15.6. Vermont Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3.16. New Hampshire
9.3.16.1. Overview
9.3.16.2. New Hampshire Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.16.3. New Hampshire Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.16.4. New Hampshire Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.16.6. New Hampshire Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3.17. Rhode Island
9.3.17.1. Overview
9.3.17.2. Rhode Island Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.17.3. Rhode Island Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.17.4. Rhode Island Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.17.6. Rhode Island Robotic Procedure Volume, Installed Base and Adoption Outlook

9.3.18. Delaware
9.3.18.1. Overview
9.3.18.2. Delaware Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.18.3. Delaware Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.3.18.4. Delaware Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.18.6. Delaware Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4. South Region

9.4.1. Regional Overview & Trends
9.4.2. South Region Surgical Robotics Manufacturers and Procurement Ecosystem
9.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.4.4. South Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.5. South Region Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.6. South Region Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.8. South Region Robotic Procedure Volume, Installed Base and ASC Adoption Outlook

9.4.9. Texas
9.4.9.1. Overview
9.4.9.2. Texas Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.9.3. Texas Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.9.4. Texas Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.9.6. Texas Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.10. Florida
9.4.10.1. Overview
9.4.10.2. Florida Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.10.3. Florida Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.10.4. Florida Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.10.6. Florida Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.11. Georgia
9.4.11.1. Overview
9.4.11.2. Georgia Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.11.3. Georgia Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.11.4. Georgia Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.11.6. Georgia Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.12. North Carolina
9.4.12.1. Overview
9.4.12.2. North Carolina Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.12.3. North Carolina Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.12.4. North Carolina Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.12.6. North Carolina Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.13. Tennessee
9.4.13.1. Overview
9.4.13.2. Tennessee Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.13.3. Tennessee Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.13.4. Tennessee Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.13.6. Tennessee Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.14. South Carolina
9.4.14.1. Overview
9.4.14.2. South Carolina Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.14.3. South Carolina Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.14.4. South Carolina Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.14.6. South Carolina Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.15. Alabama
9.4.15.1. Overview
9.4.15.2. Alabama Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.15.3. Alabama Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.15.4. Alabama Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.15.6. Alabama Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.16. Mississippi
9.4.16.1. Overview
9.4.16.2. Mississippi Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.16.3. Mississippi Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.16.4. Mississippi Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.16.6. Mississippi Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.17. Louisiana
9.4.17.1. Overview
9.4.17.2. Louisiana Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.17.3. Louisiana Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.17.4. Louisiana Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.17.6. Louisiana Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.18. Arkansas
9.4.18.1. Overview
9.4.18.2. Arkansas Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.18.3. Arkansas Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.18.4. Arkansas Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.18.6. Arkansas Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.19. Kentucky
9.4.19.1. Overview
9.4.19.2. Kentucky Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.19.3. Kentucky Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.19.4. Kentucky Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.19.6. Kentucky Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.20. Oklahoma
9.4.20.1. Overview
9.4.20.2. Oklahoma Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.20.3. Oklahoma Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.20.4. Oklahoma Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.20.6. Oklahoma Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.21. Virginia
9.4.21.1. Overview
9.4.21.2. Virginia Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.21.3. Virginia Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.21.4. Virginia Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.21.6. Virginia Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.22. Maryland
9.4.22.1. Overview
9.4.22.2. Maryland Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.22.3. Maryland Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.22.4. Maryland Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.22.6. Maryland Robotic Procedure Volume, Installed Base and Adoption Outlook

9.4.23. West Virginia
9.4.23.1. Overview
9.4.23.2. West Virginia Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.23.3. West Virginia Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.4.23.4. West Virginia Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.23.6. West Virginia Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5. Midwest Region

9.5.1. Regional Overview & Trends
9.5.2. Midwest Region Surgical Robotics Manufacturers and Procurement Ecosystem
9.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.5.4. Midwest Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.5. Midwest Region Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.6. Midwest Region Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.8. Midwest Region Robotic Procedure Volume, Installed Base and ASC Adoption Outlook

9.5.9. Illinois
9.5.9.1. Overview
9.5.9.2. Illinois Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.9.3. Illinois Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.9.4. Illinois Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.9.6. Illinois Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.10. Ohio
9.5.10.1. Overview
9.5.10.2. Ohio Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.10.3. Ohio Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.10.4. Ohio Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.10.6. Ohio Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.11. Michigan
9.5.11.1. Overview
9.5.11.2. Michigan Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.11.3. Michigan Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.11.4. Michigan Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.11.6. Michigan Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.12. Minnesota
9.5.12.1. Overview
9.5.12.2. Minnesota Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.12.3. Minnesota Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.12.4. Minnesota Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.12.6. Minnesota Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.13. Indiana
9.5.13.1. Overview
9.5.13.2. Indiana Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.13.3. Indiana Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.13.4. Indiana Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.13.6. Indiana Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.14. Wisconsin
9.5.14.1. Overview
9.5.14.2. Wisconsin Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.14.3. Wisconsin Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.14.4. Wisconsin Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.14.6. Wisconsin Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.15. Missouri
9.5.15.1. Overview
9.5.15.2. Missouri Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.15.3. Missouri Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.15.4. Missouri Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.15.6. Missouri Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.16. Iowa
9.5.16.1. Overview
9.5.16.2. Iowa Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.16.3. Iowa Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.16.4. Iowa Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.16.6. Iowa Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.17. Kansas
9.5.17.1. Overview
9.5.17.2. Kansas Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.17.3. Kansas Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.17.4. Kansas Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.17.6. Kansas Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.18. Nebraska
9.5.18.1. Overview
9.5.18.2. Nebraska Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.18.3. Nebraska Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.18.4. Nebraska Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.18.6. Nebraska Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.19. North Dakota
9.5.19.1. Overview
9.5.19.2. North Dakota Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.19.3. North Dakota Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.19.4. North Dakota Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.19.6. North Dakota Robotic Procedure Volume, Installed Base and Adoption Outlook

9.5.20. South Dakota
9.5.20.1. Overview
9.5.20.2. South Dakota Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.20.3. South Dakota Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
9.5.20.4. South Dakota Market Size and Forecast, By Robotic Technology Type, 2021–2035 (US$ Billion)
9.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.20.6. South Dakota Robotic Procedure Volume, Installed Base and Adoption Outlook

What this section provides: This section delivers detailed regional and state-level analysis of all 50 U.S. states, enabling clients to identify robotic procedure-volume hubs, installed-base concentrations, hospital and ASC adoption hotspots, technology penetration patterns, and state-level commercial opportunities.

10. U.S. Robot-Assisted Minimally Invasive Surgery Market: Competitive Landscape & Company Profiles

10.1. Market Share Analysis, 2025
10.2. Competitive Benchmarking by Robotic Platform
10.3. Installed Base Benchmarking
10.4. Robotic Procedure Volume Benchmarking
10.5. Instruments and Accessories Ecosystem Benchmarking
10.6. Capital Pricing and Commercial Model Benchmarking
10.7. Company Positioning Matrix
10.7.1. Leaders
10.7.2. Challengers
10.7.3. Innovators
10.7.4. Emerging Players

10.8. Company Profiles

10.8.1. Intuitive Surgical, Inc.
10.8.2. Medtronic plc
10.8.3. Johnson & Johnson MedTech
10.8.4. Stryker Corporation
10.8.5. Zimmer Biomet Holdings, Inc.
10.8.6. Smith+Nephew plc
10.8.7. Globus Medical, Inc.
10.8.8. CMR Surgical Ltd.
10.8.9. Distalmotion SA
10.8.10. Virtual Incision Corporation
10.8.11. Moon Surgical
10.8.12. KARL STORZ / Asensus Surgical
10.8.13. THINK Surgical, Inc.
10.8.14. PROCEPT BioRobotics Corporation
10.8.15. Momentis Surgical Ltd.
10.8.16. Medical Microinstruments, Inc.
10.8.17. Vicarious Surgical Inc.
10.8.18. EndoQuest Robotics, Inc.
10.8.19. Noah Medical Corporation
10.8.20. Brainlab AG
10.8.21. Renishaw plc
10.8.22. Corin Group
10.8.23. eCential Robotics
10.8.24. Microbot Medical Inc.

10.9. Company Profile Parameters
10.9.1. Company Overview
10.9.2. Surgical Robotics Portfolio
10.9.3. U.S. Installed Base and Commercial Presence
10.9.4. Key Applications and FDA-Cleared Indications
10.9.5. Instruments, Accessories and Recurring Revenue Model
10.9.6. U.S. Market Strategy
10.9.7. Financial and Investment Positioning
10.9.8. Clinical Pipeline and Regulatory Updates
10.9.9. Partnerships, Collaborations and Distribution Strategy
10.9.10. Recent Developments

What this section provides: This section provides competitor benchmarking, installed-base visibility, robotic platform positioning, procedure exposure, recurring-revenue economics, innovation direction, and strategic intelligence on established and emerging surgical robotics companies.

11. U.S. Robot-Assisted Minimally Invasive Surgery Market: Future Market Outlook, 2026–2035

11.1. Scenario Analysis
11.1.1. Optimistic Scenario
11.1.2. Realistic Scenario
11.1.3. Pessimistic Scenario

11.2. Disruptive Technologies Impact
11.2.1. Fifth-Generation Robotic Surgery Platforms
11.2.2. Single-Port Surgical Robotics
11.2.3. Miniaturized Intracorporeal Robotics
11.2.4. Modular Robotic Platforms
11.2.5. Force-Sensing and Haptic Feedback
11.2.6. AI-Assisted Surgical Guidance
11.2.7. Surgical Video Intelligence and Procedure Analytics
11.2.8. Collaborative Surgical Robotics
11.2.9. Semi-Autonomous Surgical Task Execution
11.2.10. Advanced Imaging and Robotic Navigation Integration

11.3. Future Robotic Procedure Penetration Analysis
11.4. Surgical Robot Replacement Opportunity, 2026–2035
11.5. Multi-Vendor Hospital Robotic Fleet Outlook
11.6. ASC Surgical Robotics Adoption Outlook
11.7. Software and Recurring Digital Revenue Opportunity
11.8. Emerging Business Models
11.8.1. Capital Purchase
11.8.2. Operating Lease
11.8.3. Usage-Based Leasing
11.8.4. Procedure-Based Commercial Models
11.8.5. Enterprise Robotic Fleet Contracts

11.9. Business Opportunities for Startups and Existing Players
11.10. Investment Prioritization Matrix
11.11. Technology Readiness and Commercialization Matrix
11.12. Unmet Need Analysis

What this section provides: This section prepares clients for changes in robotic architecture, autonomy, AI integration, procedure penetration, fleet replacement, outpatient deployment, and commercial models expected to reshape the market through 2035.

12. U.S. Robot-Assisted Minimally Invasive Surgery Market: Strategic Recommendations

12.1. Recommendations for Surgical Robotic System Manufacturers
12.2. Recommendations for Instruments and Accessories Manufacturers
12.3. Recommendations for Hospitals and Integrated Delivery Networks
12.4. Recommendations for Ambulatory Surgery Centers
12.5. Recommendations for Investors and Private Equity Firms
12.6. Recommendations for Distributors and Channel Partners
12.7. Recommendations for New Entrants and Startups
12.8. U.S. Go-to-Market Strategy Considerations
12.9. Robotic Platform Positioning Strategy
12.10. Surgeon Training and KOL Development Strategy
12.11. Hospital Value Analysis Committee Engagement Strategy
12.12. Pricing, Leasing and Procedure-Based Contracting Strategy
12.13. Product Portfolio Expansion Guidance
12.14. State and Regional Commercial Prioritization
12.15. M&A and Strategic Partnership Opportunity Assessment

What this section provides: This section converts market intelligence into actionable recommendations for product strategy, U.S. commercialization, hospital contracting, surgeon adoption, geographic expansion, investment decisions, partnerships, and long-term competitive differentiation.

13. U.S. Robot-Assisted Minimally Invasive Surgery Market: Disclaimer

13.1. Scope Limitation
13.2. Data Use Limitation
13.3. Market Sizing and Forecasting Limitation
13.4. Robotic Procedure Volume Estimation Limitation
13.5. Installed Base Estimation Limitation
13.6. Legal Disclaimer
13.7. Third-Party Data Disclaimer
13.8. Company and Regulatory Information Disclaimer

What this section provides: This section defines the report’s scope limitations, forecasting assumptions, data-use boundaries, procedural and installed-base estimation limitations, third-party information conditions, and legal considerations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Robot-Assisted Minimally Invasive Surgery Market: Market Definition and Scope
TABLE 3: U.S. Robot-Assisted Minimally Invasive Surgery Market: Research Methodology Framework
TABLE 4: U.S. Robot-Assisted Minimally Invasive Surgery Market: Key Assumptions
TABLE 5: U.S. Robot-Assisted Minimally Invasive Surgery Market: Market Ecosystem Overview
TABLE 6: U.S. Robot-Assisted Minimally Invasive Surgery Market: Stakeholder Analysis
TABLE 7: U.S. Robot-Assisted Minimally Invasive Surgery Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Robot-Assisted Minimally Invasive Surgery Market: Analyst Viewpoint Summary
TABLE 9: U.S. Robot-Assisted Minimally Invasive Surgery Market: Market Attractiveness Index
TABLE 10: U.S. Robot-Assisted Minimally Invasive Surgery Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Robot-Assisted Minimally Invasive Surgery Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Robot-Assisted Minimally Invasive Surgery Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Robot-Assisted Minimally Invasive Surgery Market: High-Growth Opportunity Areas
TABLE 14: U.S. Robot-Assisted Minimally Invasive Surgery Market: Drivers; Impact Analysis
TABLE 15: U.S. Robot-Assisted Minimally Invasive Surgery Market: Restraints; Impact Analysis
TABLE 16: U.S. Robot-Assisted Minimally Invasive Surgery Market: Opportunities; Impact Analysis
TABLE 17: U.S. Robot-Assisted Minimally Invasive Surgery Market: Challenges; Impact Analysis
TABLE 18: U.S. Robot-Assisted Minimally Invasive Surgery Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Robot-Assisted Minimally Invasive Surgery Market: Robotic Procedure Adoption Curve Analysis
TABLE 20: U.S. Robot-Assisted Minimally Invasive Surgery Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Robot-Assisted Minimally Invasive Surgery Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Robot-Assisted Minimally Invasive Surgery Market: Total Cost per Robotic Procedure Analysis
TABLE 23: U.S. Robot-Assisted Minimally Invasive Surgery Market: Robotic System Replacement Cycle Analysis
TABLE 24: U.S. Robot-Assisted Minimally Invasive Surgery Market: Hospital vs. ASC Robotic Surgery Economics
TABLE 25: U.S. Robot-Assisted Minimally Invasive Surgery Market: PESTEL Analysis
TABLE 26: U.S. Robot-Assisted Minimally Invasive Surgery Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Robot-Assisted Minimally Invasive Surgery Market: Surgical Robotic System Pricing Trends, 2025–2035
TABLE 28: U.S. Robot-Assisted Minimally Invasive Surgery Market: Instruments and Accessories Pricing Trends
TABLE 29: U.S. Robot-Assisted Minimally Invasive Surgery Market: Value Chain Analysis
TABLE 30: U.S. Robot-Assisted Minimally Invasive Surgery Market: Supply Chain Analysis
TABLE 31: U.S. Robot-Assisted Minimally Invasive Surgery Market: Capital Purchase, Leasing and Usage-Based Business Models
TABLE 32: U.S. Robot-Assisted Minimally Invasive Surgery Market: Surgical Robot Installed Base Analysis
TABLE 33: U.S. Robot-Assisted Minimally Invasive Surgery Market: Robotic Procedure Utilization Analysis
TABLE 34: U.S. Robot-Assisted Minimally Invasive Surgery Market: Robotic Operating Room Workflow Analysis
TABLE 35: U.S. Robot-Assisted Minimally Invasive Surgery Market: Digitalization and Connected OR Impact
TABLE 36: U.S. Robot-Assisted Minimally Invasive Surgery Market: AI and Surgical Data Analytics Landscape
TABLE 37: U.S. Robot-Assisted Minimally Invasive Surgery Market: FDA Regulatory Framework Analysis
TABLE 38: U.S. Robot-Assisted Minimally Invasive Surgery Market: CMS Reimbursement and Coverage Landscape
TABLE 39: U.S. Robot-Assisted Minimally Invasive Surgery Market: Cybersecurity and Device Connectivity Requirements
TABLE 40: U.S. Robot-Assisted Minimally Invasive Surgery Market: Hospital Value Analysis Committee Decision Framework
TABLE 41: U.S. Robot-Assisted Minimally Invasive Surgery Market: Component Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Component
TABLE 43: U.S. Robot-Assisted Minimally Invasive Surgery Market, by Component, 2021–2035 (US$ Billion)
TABLE 44: U.S. Robot-Assisted Minimally Invasive Surgery Market: Segment Share Analysis, by Component, 2025 & 2035 (%)
TABLE 45: Robotic Surgical Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: Instruments and Accessories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: Services and Maintenance Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: Software and Digital Surgical Workflow Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Robot-Assisted Minimally Invasive Surgery Market: Surgical Application Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Surgical Application
TABLE 51: U.S. Robot-Assisted Minimally Invasive Surgery Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 52: U.S. Robot-Assisted Minimally Invasive Surgery Market: Segment Share Analysis, by Surgical Application, 2025 & 2035 (%)
TABLE 53: General and Gastrointestinal Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Urology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Gynecology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Orthopedic and Spine Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: Cardiothoracic and Other Complex MIS Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Robot-Assisted Minimally Invasive Surgery Market: Robotic Technology Type Snapshot, 2025
TABLE 59: Segment Dashboard; Definition and Scope, by Robotic Technology Type
TABLE 60: U.S. Robot-Assisted Minimally Invasive Surgery Market, by Robotic Technology Type, 2021–2035 (US$ Billion)
TABLE 61: U.S. Robot-Assisted Minimally Invasive Surgery Market: Segment Share Analysis, by Robotic Technology Type, 2025 & 2035 (%)
TABLE 62: Multi-Port Teleoperated Robotic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Single-Port and Miniaturized Robotic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Modular and Open-Console Robotic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Robotic Orthopedic and Spine Guidance Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: AI-Enhanced Collaborative and Assistive Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Robot-Assisted Minimally Invasive Surgery Market: End User Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by End User
TABLE 69: U.S. Robot-Assisted Minimally Invasive Surgery Market, by End User, 2021–2035 (US$ Billion)
TABLE 70: U.S. Robot-Assisted Minimally Invasive Surgery Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 71: Large Hospitals and Integrated Delivery Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Academic and Tertiary Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Community Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Ambulatory Surgery Centers and Hospital Outpatient Departments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Specialty Surgical Hospitals and Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Robot-Assisted Minimally Invasive Surgery Market: Regional Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by Geography
TABLE 78: U.S. Robot-Assisted Minimally Invasive Surgery Market, by Region, 2021–2035 (US$ Billion)
TABLE 79: U.S. Robot-Assisted Minimally Invasive Surgery Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 80: U.S. Robot-Assisted Minimally Invasive Surgery Market: Regional Robotic Procedure Volume and Installed Base Analysis
TABLE 81: West Region: Regional Overview and Trends
TABLE 82: West Region: Surgical Robotics Manufacturers and Procurement Ecosystem
TABLE 83: West Region Market, by State, 2021–2035 (US$ Billion)
TABLE 84: West Region Market, by Component, 2021–2035 (US$ Billion)
TABLE 85: West Region Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 86: West Region Market, by Robotic Technology Type, 2021–2035 (US$ Billion)
TABLE 87: West Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 88: West Region: Robotic Procedure Volume, Installed Base and ASC Adoption Outlook
TABLE 89: California Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: Washington Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: Arizona Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: Colorado Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Oregon Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Utah Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Nevada Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: New Mexico Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Idaho Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Montana Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Wyoming Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Alaska Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Hawaii Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Northeast Region: Regional Overview and Trends
TABLE 103: Northeast Region: Surgical Robotics Manufacturers and Procurement Ecosystem
TABLE 104: Northeast Region Market, by State, 2021–2035 (US$ Billion)
TABLE 105: Northeast Region Market, by Component, 2021–2035 (US$ Billion)
TABLE 106: Northeast Region Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 107: Northeast Region Market, by Robotic Technology Type, 2021–2035 (US$ Billion)
TABLE 108: Northeast Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 109: Northeast Region: Robotic Procedure Volume, Installed Base and ASC Adoption Outlook
TABLE 110: New York Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Massachusetts Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: New Jersey Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Pennsylvania Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Connecticut Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Maine Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Vermont Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: New Hampshire Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Rhode Island Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Delaware Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: South Region: Regional Overview and Trends
TABLE 121: South Region: Surgical Robotics Manufacturers and Procurement Ecosystem
TABLE 122: South Region Market, by State, 2021–2035 (US$ Billion)
TABLE 123: South Region Market, by Component, 2021–2035 (US$ Billion)
TABLE 124: South Region Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 125: South Region Market, by Robotic Technology Type, 2021–2035 (US$ Billion)
TABLE 126: South Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 127: South Region: Robotic Procedure Volume, Installed Base and ASC Adoption Outlook
TABLE 128: Texas Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Florida Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Georgia Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: North Carolina Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Tennessee Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: South Carolina Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Alabama Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Mississippi Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Louisiana Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Arkansas Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Kentucky Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Oklahoma Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Virginia Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Maryland Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: West Virginia Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Midwest Region: Regional Overview and Trends
TABLE 144: Midwest Region: Surgical Robotics Manufacturers and Procurement Ecosystem
TABLE 145: Midwest Region Market, by State, 2021–2035 (US$ Billion)
TABLE 146: Midwest Region Market, by Component, 2021–2035 (US$ Billion)
TABLE 147: Midwest Region Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 148: Midwest Region Market, by Robotic Technology Type, 2021–2035 (US$ Billion)
TABLE 149: Midwest Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 150: Midwest Region: Robotic Procedure Volume, Installed Base and ASC Adoption Outlook
TABLE 151: Illinois Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Ohio Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Michigan Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Minnesota Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Indiana Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Wisconsin Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Missouri Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: Iowa Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Kansas Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Nebraska Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: North Dakota Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: South Dakota Robot-Assisted Minimally Invasive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: U.S. Robot-Assisted Minimally Invasive Surgery Market: Competitive Landscape Snapshot, 2025
TABLE 164: U.S. Robot-Assisted Minimally Invasive Surgery Market: Key Company Market Share Analysis, 2025
TABLE 165: U.S. Robot-Assisted Minimally Invasive Surgery Market: Competitive Benchmarking by Robotic Platform
TABLE 166: U.S. Robot-Assisted Minimally Invasive Surgery Market: Installed Base Benchmarking
TABLE 167: U.S. Robot-Assisted Minimally Invasive Surgery Market: Robotic Procedure Volume Benchmarking
TABLE 168: U.S. Robot-Assisted Minimally Invasive Surgery Market: Instruments and Accessories Ecosystem Benchmarking
TABLE 169: U.S. Robot-Assisted Minimally Invasive Surgery Market: Commercial Model and Capital Pricing Benchmarking
TABLE 170: U.S. Robot-Assisted Minimally Invasive Surgery Market: Company Positioning Matrix
TABLE 171: Intuitive Surgical, Inc.: Company Profile
TABLE 172: Medtronic plc: Company Profile
TABLE 173: Johnson & Johnson MedTech: Company Profile
TABLE 174: Stryker Corporation: Company Profile
TABLE 175: Zimmer Biomet Holdings, Inc.: Company Profile
TABLE 176: Smith+Nephew plc: Company Profile
TABLE 177: Globus Medical, Inc.: Company Profile
TABLE 178: CMR Surgical Ltd.: Company Profile
TABLE 179: Distalmotion SA: Company Profile
TABLE 180: Virtual Incision Corporation: Company Profile
TABLE 181: Moon Surgical: Company Profile
TABLE 182: KARL STORZ / Asensus Surgical: Company Profile
TABLE 183: THINK Surgical, Inc.: Company Profile
TABLE 184: PROCEPT BioRobotics Corporation: Company Profile
TABLE 185: Momentis Surgical Ltd.: Company Profile
TABLE 186: Medical Microinstruments, Inc.: Company Profile
TABLE 187: Vicarious Surgical Inc.: Company Profile
TABLE 188: EndoQuest Robotics, Inc.: Company Profile
TABLE 189: Noah Medical Corporation: Company Profile
TABLE 190: Brainlab AG: Company Profile
TABLE 191: Renishaw plc: Company Profile
TABLE 192: Corin Group: Company Profile
TABLE 193: eCential Robotics: Company Profile
TABLE 194: Microbot Medical Inc.: Company Profile
TABLE 195: U.S. Robot-Assisted Minimally Invasive Surgery Market: Future Market Scenario Analysis, 2026–2035
TABLE 196: U.S. Robot-Assisted Minimally Invasive Surgery Market: Disruptive Technologies Impact Matrix
TABLE 197: U.S. Robot-Assisted Minimally Invasive Surgery Market: Future Robotic Procedure Penetration Analysis
TABLE 198: U.S. Robot-Assisted Minimally Invasive Surgery Market: Surgical Robot Replacement Opportunity, 2026–2035
TABLE 199: U.S. Robot-Assisted Minimally Invasive Surgery Market: Multi-Vendor Robotic Fleet Outlook
TABLE 200: U.S. Robot-Assisted Minimally Invasive Surgery Market: ASC Surgical Robotics Adoption Outlook
TABLE 201: U.S. Robot-Assisted Minimally Invasive Surgery Market: Software and Digital Revenue Opportunity
TABLE 202: U.S. Robot-Assisted Minimally Invasive Surgery Market: Emerging Business Models
TABLE 203: U.S. Robot-Assisted Minimally Invasive Surgery Market: Business Opportunities for Startups and Existing Players
TABLE 204: U.S. Robot-Assisted Minimally Invasive Surgery Market: Investment Prioritization Matrix
TABLE 205: U.S. Robot-Assisted Minimally Invasive Surgery Market: Technology Readiness and Commercialization Matrix
TABLE 206: U.S. Robot-Assisted Minimally Invasive Surgery Market: Unmet Need Analysis
TABLE 207: Strategic Recommendations for Surgical Robotic System Manufacturers
TABLE 208: Strategic Recommendations for Instruments and Accessories Manufacturers
TABLE 209: Strategic Recommendations for Hospitals and Integrated Delivery Networks
TABLE 210: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 211: Strategic Recommendations for Investors and Private Equity Firms
TABLE 212: Strategic Recommendations for New Entrants and Startups
TABLE 213: U.S. Robot-Assisted Minimally Invasive Surgery Market: Go-to-Market Strategy Considerations
TABLE 214: U.S. Robot-Assisted Minimally Invasive Surgery Market: Surgeon Training and KOL Development Strategy
TABLE 215: U.S. Robot-Assisted Minimally Invasive Surgery Market: Pricing, Leasing and Procedure-Based Contracting Strategy
TABLE 216: U.S. Robot-Assisted Minimally Invasive Surgery Market: State and Regional Commercial Prioritization
TABLE 217: U.S. Robot-Assisted Minimally Invasive Surgery Market: M&A and Strategic Partnership Opportunity Assessment
TABLE 218: U.S. Robot-Assisted Minimally Invasive Surgery Market: Scope Limitation
TABLE 219: U.S. Robot-Assisted Minimally Invasive Surgery Market: Data Use Limitation
TABLE 220: U.S. Robot-Assisted Minimally Invasive Surgery Market: Market Sizing and Forecasting Limitation
TABLE 221: U.S. Robot-Assisted Minimally Invasive Surgery Market: Robotic Procedure Volume Estimation Limitation
TABLE 222: U.S. Robot-Assisted Minimally Invasive Surgery Market: Installed Base Estimation Limitation
TABLE 223: U.S. Robot-Assisted Minimally Invasive Surgery Market: Legal Disclaimer
TABLE 224: U.S. Robot-Assisted Minimally Invasive Surgery Market: Third-Party Data Disclaimer
TABLE 225: U.S. Robot-Assisted Minimally Invasive Surgery Market: Company and Regulatory Information Disclaimer

List of Figures

FIGURE 1: U.S. Robot-Assisted Minimally Invasive Surgery Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem Framework
FIGURE 4: Stakeholder Ecosystem
FIGURE 5: Historical Market Size Trend, 2021–2024 (US$ Billion)
FIGURE 6: Market Size Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 7: Year-wise Market Growth Curve, 2021–2035
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Robotic Procedure Volume Growth Outlook
FIGURE 10: U.S. Surgical Robot Installed Base and Replacement Cycle Outlook
FIGURE 11: Market Dynamics
FIGURE 12: Robot-Assisted Surgery Adoption Curve
FIGURE 13: Clinical Workflow Economics Framework
FIGURE 14: Hospital Capital Procurement Decision Framework
FIGURE 15: Total Cost per Robotic Procedure Framework
FIGURE 16: Hospital vs. ASC Robotic Surgery Economics
FIGURE 17: Innovation & Patent Landscape, 2021–2025
FIGURE 18: PESTEL Analysis
FIGURE 19: Porter’s Five Forces Analysis
FIGURE 20: Value Chain Analysis
FIGURE 21: Supply Chain Analysis
FIGURE 22: Surgical Robotic System Pricing Trend, 2025–2035
FIGURE 23: Robotic Operating Room Workflow
FIGURE 24: Connected Operating Room and Digital Surgery Ecosystem
FIGURE 25: AI and Surgical Data Analytics Landscape
FIGURE 26: FDA Regulatory Pathway Framework
FIGURE 27: CMS Reimbursement and Robotic Surgery Economics Framework
FIGURE 28: Component Segment Market Share Analysis, 2025 & 2035
FIGURE 29: Component Segment Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 30: Robotic Surgical Systems Market Size Forecast, 2021–2035
FIGURE 31: Instruments and Accessories Market Size Forecast, 2021–2035
FIGURE 32: Services and Maintenance Market Size Forecast, 2021–2035
FIGURE 33: Software and Digital Surgical Workflow Market Size Forecast, 2021–2035
FIGURE 34: Surgical Application Segment Market Share Analysis, 2025 & 2035
FIGURE 35: Surgical Application Market Size Forecast, 2021–2035
FIGURE 36: General and Gastrointestinal Surgery Market Size Forecast, 2021–2035
FIGURE 37: Urology Market Size Forecast, 2021–2035
FIGURE 38: Gynecology Market Size Forecast, 2021–2035
FIGURE 39: Orthopedic and Spine Surgery Market Size Forecast, 2021–2035
FIGURE 40: Cardiothoracic and Other Complex MIS Procedures Market Size Forecast, 2021–2035
FIGURE 41: Robotic Technology Type Market Share Analysis, 2025 & 2035
FIGURE 42: Robotic Technology Type Market Size Forecast, 2021–2035
FIGURE 43: Multi-Port Teleoperated Robotic Systems Market Size Forecast, 2021–2035
FIGURE 44: Single-Port and Miniaturized Robotic Systems Market Size Forecast, 2021–2035
FIGURE 45: Modular and Open-Console Robotic Systems Market Size Forecast, 2021–2035
FIGURE 46: Robotic Orthopedic and Spine Guidance Systems Market Size Forecast, 2021–2035
FIGURE 47: AI-Enhanced Collaborative and Assistive Robotics Market Size Forecast, 2021–2035
FIGURE 48: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 49: End User Segment Market Size Forecast, 2021–2035
FIGURE 50: Large Hospitals and Integrated Delivery Networks Market Size Forecast, 2021–2035
FIGURE 51: Academic and Tertiary Medical Centers Market Size Forecast, 2021–2035
FIGURE 52: Community Hospitals Market Size Forecast, 2021–2035
FIGURE 53: Ambulatory Surgery Centers and Hospital Outpatient Departments Market Size Forecast, 2021–2035
FIGURE 54: Specialty Surgical Hospitals and Centers Market Size Forecast, 2021–2035
FIGURE 55: Regional Market Share Analysis, 2025 & 2035
FIGURE 56: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Regional Robotic Procedure Volume and Installed Base Comparison
FIGURE 58: West Region Market Share Analysis by State, 2025
FIGURE 59: West Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 60: West Region Robotic Procedure Volume, Installed Base and ASC Adoption Outlook
FIGURE 61: California Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 62: Washington Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 63: Arizona Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 64: Colorado Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 65: Oregon Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 66: Utah Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 67: Nevada Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 68: New Mexico Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 69: Idaho Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 70: Montana Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 71: Wyoming Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 72: Alaska Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 73: Hawaii Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 74: Northeast Region Market Share Analysis by State, 2025
FIGURE 75: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 76: Northeast Region Robotic Procedure Volume, Installed Base and ASC Adoption Outlook
FIGURE 77: New York Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 78: Massachusetts Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 79: New Jersey Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 80: Pennsylvania Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 81: Connecticut Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 82: Maine Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 83: Vermont Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 84: New Hampshire Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 85: Rhode Island Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 86: Delaware Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 87: South Region Market Share Analysis by State, 2025
FIGURE 88: South Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 89: South Region Robotic Procedure Volume, Installed Base and ASC Adoption Outlook
FIGURE 90: Texas Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 91: Florida Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 92: Georgia Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 93: North Carolina Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 94: Tennessee Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 95: South Carolina Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 96: Alabama Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 97: Mississippi Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 98: Louisiana Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 99: Arkansas Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 100: Kentucky Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 101: Oklahoma Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 102: Virginia Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 103: Maryland Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 104: West Virginia Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 105: Midwest Region Market Share Analysis by State, 2025
FIGURE 106: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 107: Midwest Region Robotic Procedure Volume, Installed Base and ASC Adoption Outlook
FIGURE 108: Illinois Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 109: Ohio Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 110: Michigan Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 111: Minnesota Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 112: Indiana Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 113: Wisconsin Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 114: Missouri Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 115: Iowa Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 116: Kansas Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 117: Nebraska Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 118: North Dakota Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 119: South Dakota Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 120: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 121: Company Positioning Matrix
FIGURE 122: Robotic Platform Competitive Benchmarking
FIGURE 123: Surgical Robot Installed Base Benchmarking
FIGURE 124: Robotic Procedure Volume Benchmarking
FIGURE 125: Instruments and Accessories Ecosystem Benchmarking
FIGURE 126: Capital Pricing and Commercial Model Benchmarking
FIGURE 127: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 128: U.S. Surgical Robotics Innovation Roadmap
FIGURE 129: Fifth-Generation Robotic Platform Adoption Roadmap
FIGURE 130: Single-Port and Miniaturized Robotics Opportunity Map
FIGURE 131: Modular and Collaborative Robotics Technology Roadmap
FIGURE 132: AI-Assisted Surgical Robotics Development Roadmap
FIGURE 133: Future Market Scenario Analysis, 2026–2035
FIGURE 134: Disruptive Technologies Impact Matrix
FIGURE 135: Future Robotic Procedure Penetration Outlook
FIGURE 136: Surgical Robot Replacement Opportunity, 2026–2035
FIGURE 137: ASC Surgical Robotics Adoption Roadmap
FIGURE 138: Multi-Vendor Robotic Fleet Evolution
FIGURE 139: Emerging Business Models Matrix
FIGURE 140: Investment Prioritization Matrix
FIGURE 141: Technology Readiness and Commercialization Matrix
FIGURE 142: Strategic Growth Roadmap for Surgical Robotics Manufacturers
FIGURE 143: Hospital and IDN Robotic Procurement Strategy Framework
FIGURE 144: U.S. Go-to-Market Strategy Framework
FIGURE 145: Surgeon Training and KOL Development Framework
FIGURE 146: Pricing, Leasing and Procedure-Based Contracting Framework
FIGURE 147: State and Regional Commercial Prioritization Matrix
FIGURE 148: M&A and Strategic Partnership Opportunity Map
FIGURE 149: Report Scope, Data Limitations and Disclaimer Framework